> top > docs > PubMed:10872036 > annotations

PubMed:10872036 JSONTXT

Annnotations TAB JSON ListView MergeView

c_corpus

Id Subject Object Predicate Lexical cue
T1 18-45 D002285 denotes atypical ductal hyperplasia
T2 18-45 D002285 denotes atypical ductal hyperplasia
T5 50-71 D002285 denotes intraductal carcinoma
T6 50-71 D002285 denotes intraductal carcinoma
T9 79-85 UBERON:0000310 denotes breast
T10 173-182 UBERON:3010449 denotes organizer
T11 173-182 UBERON:0003062 denotes organizer
T12 173-182 UBERON:3010457 denotes organizer
T13 192-198 C051963 denotes AgNORs
T14 192-198 C051963 denotes AgNORs
T15 203-230 D002285 denotes atypical ductal hyperplasia
T16 203-230 D002285 denotes atypical ductal hyperplasia
T19 232-235 P0A388 denotes ADH
T20 232-235 PR:P06525 denotes ADH
T21 232-235 Q8NXU1 denotes ADH
T22 232-235 Q6GBM4 denotes ADH
T23 232-235 Q47945 denotes ADH
T24 232-235 P0A389 denotes ADH
T25 232-235 Q5HRD6 denotes ADH
T26 232-235 P28036 denotes ADH
T27 232-235 P42327 denotes ADH
T28 232-235 PR:P00332 denotes ADH
T31 232-235 P81786 denotes ADH
T32 232-235 P18278 denotes ADH
T33 232-235 Q44002 denotes ADH
T34 232-235 Q7A742 denotes ADH
T35 232-235 O05542 denotes ADH
T36 232-235 Q2YSX0 denotes ADH
T37 232-235 Q6GJ63 denotes ADH
T38 232-235 PR:P00334 denotes ADH
T40 232-235 Q24857 denotes ADH
T41 232-235 Q8CQ56 denotes ADH
T42 232-235 Q2FJ31 denotes ADH
T43 232-235 Q2G0G1 denotes ADH
T44 232-235 PR:Q2G0G1 denotes ADH
T46 232-235 Q5HI63 denotes ADH
T47 232-235 Q99W07 denotes ADH
T48 232-235 Q04983 denotes ADH
T29 232-235 CHEBI:34543 denotes ADH
T45 232-235 CHEBI:9937 denotes ADH
T30 232-235 GO:0047636 denotes ADH
T39 232-235 GO:0004022 denotes ADH
T51 238-262 D002285 denotes ductal carcinoma in situ
T52 238-262 D002285 denotes ductal carcinoma in situ
T58 264-268 CVCL_5552 denotes DCIS
T57 264-268 D002285 denotes DCIS
T59 264-268 D002285 denotes DCIS
T60 288-304 D044584 denotes ductal carcinoma
T61 288-304 D044584 denotes ductal carcinoma
T64 306-310 CHEBI:81482 denotes MDCA
T65 319-325 UBERON:0000310 denotes breast
T66 399-405 UBERON:0000310 denotes breast
T67 406-409 P0A388 denotes ADH
T68 406-409 PR:P06525 denotes ADH
T69 406-409 Q8NXU1 denotes ADH
T70 406-409 Q6GBM4 denotes ADH
T71 406-409 Q47945 denotes ADH
T72 406-409 P0A389 denotes ADH
T73 406-409 Q5HRD6 denotes ADH
T74 406-409 P28036 denotes ADH
T75 406-409 P42327 denotes ADH
T76 406-409 PR:P00332 denotes ADH
T79 406-409 P81786 denotes ADH
T80 406-409 P18278 denotes ADH
T81 406-409 Q44002 denotes ADH
T82 406-409 Q7A742 denotes ADH
T83 406-409 O05542 denotes ADH
T84 406-409 Q2YSX0 denotes ADH
T85 406-409 Q6GJ63 denotes ADH
T86 406-409 PR:P00334 denotes ADH
T88 406-409 Q24857 denotes ADH
T89 406-409 Q8CQ56 denotes ADH
T90 406-409 Q2FJ31 denotes ADH
T91 406-409 Q2G0G1 denotes ADH
T92 406-409 PR:Q2G0G1 denotes ADH
T94 406-409 Q5HI63 denotes ADH
T95 406-409 Q99W07 denotes ADH
T96 406-409 Q04983 denotes ADH
T77 406-409 CHEBI:34543 denotes ADH
T93 406-409 CHEBI:9937 denotes ADH
T78 406-409 GO:0047636 denotes ADH
T87 406-409 GO:0004022 denotes ADH
T98 414-418 CVCL_5552 denotes DCIS
T97 414-418 D002285 denotes DCIS
T99 414-418 D002285 denotes DCIS
T100 435-439 CHEBI:81482 denotes MDCA
T101 488-494 CHEBI:33252 denotes nuclei
T102 509-518 UBERON:3010449 denotes organizer
T103 509-518 UBERON:0003062 denotes organizer
T104 509-518 UBERON:3010457 denotes organizer
T105 586-594 D004967 denotes estrogen
T106 586-594 D004967 denotes estrogen
T107 586-594 CHEBI:50114 denotes estrogen
T108 586-603 Q9PVZ9 denotes estrogen receptor
T109 586-603 Q9YHT3 denotes estrogen receptor
T110 586-603 P57717 denotes estrogen receptor
T111 586-603 Q9QZJ5 denotes estrogen receptor
T112 586-603 Q29040 denotes estrogen receptor
T113 586-603 P49886 denotes estrogen receptor
T114 586-603 P50240 denotes estrogen receptor
T115 586-603 Q91424 denotes estrogen receptor
T116 586-603 Q9YHZ7 denotes estrogen receptor
T117 586-603 P06211 denotes estrogen receptor
T118 586-603 P16058 denotes estrogen receptor
T119 586-603 P50242 denotes estrogen receptor
T120 586-603 Q53AD2 denotes estrogen receptor
T121 586-603 P49885 denotes estrogen receptor
T122 586-603 P49884 denotes estrogen receptor
T123 586-603 P19785 denotes estrogen receptor
T124 586-603 Q91250 denotes estrogen receptor
T125 586-603 P81559 denotes estrogen receptor
T126 586-603 Q9TV98 denotes estrogen receptor
T127 586-603 PR:000007204 denotes estrogen receptor
T128 586-603 Q9YH33 denotes estrogen receptor
T129 586-603 P50241 denotes estrogen receptor
T130 586-603 P06212 denotes estrogen receptor
T131 586-603 P03372 denotes estrogen receptor
T132 586-603 O42132 denotes estrogen receptor
T133 586-603 P57753 denotes estrogen receptor
T134 595-616 D011980 denotes receptor/progesterone
T136 604-616 8727 denotes progesterone
T139 604-625 Q9GLW0 denotes progesterone receptor
T140 604-625 A7XW16 denotes progesterone receptor
T141 604-625 A7X8C2 denotes progesterone receptor
T142 604-625 Q00175 denotes progesterone receptor
T143 604-625 A7X8B5 denotes progesterone receptor
T144 604-625 Q8AYI2 denotes progesterone receptor
T145 604-625 A7X8C7 denotes progesterone receptor
T146 604-625 Q63449 denotes progesterone receptor
T147 604-625 A7X8C9 denotes progesterone receptor
T148 604-625 Q28590 denotes progesterone receptor
T149 604-625 A7X8B9 denotes progesterone receptor
T150 604-625 A7X8D4 denotes progesterone receptor
T151 604-625 A7X8B3 denotes progesterone receptor
T152 604-625 P07812 denotes progesterone receptor
T153 604-625 A7XW20 denotes progesterone receptor
T154 604-625 A7X8B7 denotes progesterone receptor
T155 604-625 A7XW25 denotes progesterone receptor
T156 604-625 P06401 denotes progesterone receptor
T157 604-625 PR:000012621 denotes progesterone receptor
T158 604-625 P79373 denotes progesterone receptor
T159 604-625 P06186 denotes progesterone receptor
T160 604-625 A7X8C4 denotes progesterone receptor
T162 604-625 A7X8D2 denotes progesterone receptor
T161 604-625 D011980 denotes progesterone receptor
T163 771-774 P0A388 denotes ADH
T164 771-774 PR:P06525 denotes ADH
T165 771-774 Q8NXU1 denotes ADH
T166 771-774 Q6GBM4 denotes ADH
T167 771-774 Q47945 denotes ADH
T168 771-774 P0A389 denotes ADH
T169 771-774 Q5HRD6 denotes ADH
T170 771-774 P28036 denotes ADH
T171 771-774 P42327 denotes ADH
T172 771-774 PR:P00332 denotes ADH
T175 771-774 P81786 denotes ADH
T176 771-774 P18278 denotes ADH
T177 771-774 Q44002 denotes ADH
T178 771-774 Q7A742 denotes ADH
T179 771-774 O05542 denotes ADH
T180 771-774 Q2YSX0 denotes ADH
T181 771-774 Q6GJ63 denotes ADH
T182 771-774 PR:P00334 denotes ADH
T184 771-774 Q24857 denotes ADH
T185 771-774 Q8CQ56 denotes ADH
T186 771-774 Q2FJ31 denotes ADH
T187 771-774 Q2G0G1 denotes ADH
T188 771-774 PR:Q2G0G1 denotes ADH
T190 771-774 Q5HI63 denotes ADH
T191 771-774 Q99W07 denotes ADH
T192 771-774 Q04983 denotes ADH
T173 771-774 CHEBI:34543 denotes ADH
T189 771-774 CHEBI:9937 denotes ADH
T174 771-774 GO:0047636 denotes ADH
T183 771-774 GO:0004022 denotes ADH
T194 778-782 CVCL_5552 denotes DCIS
T193 778-782 D002285 denotes DCIS
T195 778-782 D002285 denotes DCIS
T197 829-833 CVCL_5552 denotes DCIS
T196 829-833 D002285 denotes DCIS
T198 829-833 D002285 denotes DCIS
T199 874-877 P0A388 denotes ADH
T200 874-877 PR:P06525 denotes ADH
T201 874-877 Q8NXU1 denotes ADH
T202 874-877 Q6GBM4 denotes ADH
T203 874-877 Q47945 denotes ADH
T204 874-877 P0A389 denotes ADH
T205 874-877 Q5HRD6 denotes ADH
T206 874-877 P28036 denotes ADH
T207 874-877 P42327 denotes ADH
T208 874-877 PR:P00332 denotes ADH
T211 874-877 P81786 denotes ADH
T212 874-877 P18278 denotes ADH
T213 874-877 Q44002 denotes ADH
T214 874-877 Q7A742 denotes ADH
T215 874-877 O05542 denotes ADH
T216 874-877 Q2YSX0 denotes ADH
T217 874-877 Q6GJ63 denotes ADH
T218 874-877 PR:P00334 denotes ADH
T220 874-877 Q24857 denotes ADH
T221 874-877 Q8CQ56 denotes ADH
T222 874-877 Q2FJ31 denotes ADH
T223 874-877 Q2G0G1 denotes ADH
T224 874-877 PR:Q2G0G1 denotes ADH
T226 874-877 Q5HI63 denotes ADH
T227 874-877 Q99W07 denotes ADH
T228 874-877 Q04983 denotes ADH
T209 874-877 CHEBI:34543 denotes ADH
T225 874-877 CHEBI:9937 denotes ADH
T210 874-877 GO:0047636 denotes ADH
T219 874-877 GO:0004022 denotes ADH
T229 911-927 D044584 denotes ductal carcinoma
T230 911-927 D044584 denotes ductal carcinoma
T233 980-1002 D002285 denotes intraductal carcinomas
T234 980-1002 D002285 denotes intraductal carcinomas
T237 1286-1289 P0A388 denotes ADH
T238 1286-1289 PR:P06525 denotes ADH
T239 1286-1289 Q8NXU1 denotes ADH
T240 1286-1289 Q6GBM4 denotes ADH
T241 1286-1289 Q47945 denotes ADH
T242 1286-1289 P0A389 denotes ADH
T243 1286-1289 Q5HRD6 denotes ADH
T244 1286-1289 P28036 denotes ADH
T245 1286-1289 P42327 denotes ADH
T246 1286-1289 PR:P00332 denotes ADH
T249 1286-1289 P81786 denotes ADH
T250 1286-1289 P18278 denotes ADH
T251 1286-1289 Q44002 denotes ADH
T252 1286-1289 Q7A742 denotes ADH
T253 1286-1289 O05542 denotes ADH
T254 1286-1289 Q2YSX0 denotes ADH
T255 1286-1289 Q6GJ63 denotes ADH
T256 1286-1289 PR:P00334 denotes ADH
T258 1286-1289 Q24857 denotes ADH
T259 1286-1289 Q8CQ56 denotes ADH
T260 1286-1289 Q2FJ31 denotes ADH
T261 1286-1289 Q2G0G1 denotes ADH
T262 1286-1289 PR:Q2G0G1 denotes ADH
T264 1286-1289 Q5HI63 denotes ADH
T265 1286-1289 Q99W07 denotes ADH
T266 1286-1289 Q04983 denotes ADH
T247 1286-1289 CHEBI:34543 denotes ADH
T263 1286-1289 CHEBI:9937 denotes ADH
T248 1286-1289 GO:0047636 denotes ADH
T257 1286-1289 GO:0004022 denotes ADH
T268 1294-1298 CVCL_5552 denotes DCIS
T267 1294-1298 D002285 denotes DCIS
T269 1294-1298 D002285 denotes DCIS
T271 1337-1341 CVCL_5552 denotes DCIS
T270 1337-1341 D002285 denotes DCIS
T272 1337-1341 D002285 denotes DCIS
T273 1360-1376 D044584 denotes ductal carcinoma
T274 1360-1376 D044584 denotes ductal carcinoma

UseCases_ArguminSci_Discourse

Id Subject Object Predicate Lexical cue
T1 0-86 DRI_Background denotes AgNOR analysis of atypical ductal hyperplasia and intraductal carcinoma of the breast.
T2 92-326 DRI_Background denotes TIVE: To determine the diagnostic and prognostic value of argyrophilic nucleolar organizer regions (AgNORs) in atypical ductal hyperplasia (ADH), ductal carcinoma in situ (DCIS) and microinvasive ductal carcinoma (MDCA) of the breast.
T3 336-440 DRI_Background denotes IGN: Image analysis of histologic sections from biopsies of 46 breast ADH and DCIS and 18 cases of MDCA.
T4 441-557 DRI_Background denotes Determination of morphometric features of cell nuclei and nucleolar organizer regions by using AMBA software system.
T5 558-712 DRI_Approach denotes Data were compared with the estrogen receptor/progesterone receptor (ER/PR) content as well as with the growth fraction, determined immunohistochemically.
T6 722-783 DRI_Background denotes AgNOR number and total AgNOR area increased from ADH to DCIS.
T7 784-853 DRI_Outcome denotes The highest values were recorded in cases of DCIS with microinvasion.
T8 854-959 DRI_Background denotes Differences between ADH and intraductal or microinvasive ductal carcinoma were statistically significant.
T9 960-1092 DRI_Approach denotes Within the group of intraductal carcinomas, the lowest values were measured in the solid type and highest values in the comedo type.
T10 1093-1208 DRI_Background denotes A correlation was found between AgNOR features and growth fraction but not between these features and ER/PR status.
T11 1221-1377 DRI_Background denotes Selected AgNOR features are relevant for differentiation between ADH and DCIS as well as between low and high grade DCIS and microinvasive ductal carcinoma.
T12 1378-1524 DRI_Background denotes Therefore, objective and reproducible data obtained by AgNOR analysis may allow better evaluation of the prognostic significance of these lesions.

PubMed_Structured_Abstracts

Id Subject Object Predicate Lexical cue
T1 98-326 OBJECTIVE denotes To determine the diagnostic and prognostic value of argyrophilic nucleolar organizer regions (AgNORs) in atypical ductal hyperplasia (ADH), ductal carcinoma in situ (DCIS) and microinvasive ductal carcinoma (MDCA) of the breast.
T2 341-712 METHODS denotes Image analysis of histologic sections from biopsies of 46 breast ADH and DCIS and 18 cases of MDCA. Determination of morphometric features of cell nuclei and nucleolar organizer regions by using AMBA software system. Data were compared with the estrogen receptor/progesterone receptor (ER/PR) content as well as with the growth fraction, determined immunohistochemically.
T3 722-1208 RESULTS denotes AgNOR number and total AgNOR area increased from ADH to DCIS. The highest values were recorded in cases of DCIS with microinvasion. Differences between ADH and intraductal or microinvasive ductal carcinoma were statistically significant. Within the group of intraductal carcinomas, the lowest values were measured in the solid type and highest values in the comedo type. A correlation was found between AgNOR features and growth fraction but not between these features and ER/PR status.
T4 1221-1524 CONCLUSIONS denotes Selected AgNOR features are relevant for differentiation between ADH and DCIS as well as between low and high grade DCIS and microinvasive ductal carcinoma. Therefore, objective and reproducible data obtained by AgNOR analysis may allow better evaluation of the prognostic significance of these lesions.